Notably, pharmacological inhibition of the activity of ACK1 not only alleviated the conditions of TLR4-mediated endotoxic shock mice but also relieved the conditions of TLR7-mediated lupus model mice. The gene discussed is TLR4; the disease is systemic lupus erythematosus.